Journal profile · Mathematics-Statistics and Probability
Frontiers in Bioinformatics
ISSN 2673-7647 · Frontiers Media S.A. · Switzerland
Frontiers in Bioinformatics: CAS Zone 4 · Biology (2025 upgraded edition); impact factor 3.6 (journal website); fully open access; APC charged, amount not published; median 63 days to acceptance (115 articles, last 24 months); 165 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Frontiers in Bioinformatics is published by Frontiers Media S.A. and is in Zone 4 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Bioinformatics and Genomic Networks, Genomics and Phylogenetic Studies and Computational Drug Discovery Methods, together about 28% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Frontiers in Bioinformatics is a multidisciplinary journal that investigates the tools and algorithms used to analyze biological data. Led by Field Chief Prof Editor Adam Godzik (University of California, Riverside, USA), the journal, indexed in PubMed Central, DOAJ, Scopus and WoS ESCI, seeks research that combines biological insights with computer science, mathematics, and statistics enabling analysis and interpretation of biological data. This journal covers a wide range of topics, including but not limited to: computational bioimaging data visualization drug discovery in bioinformatics genomic analysis integrative bioinformatics network bioinformatics protein bioinformatics RNA bioinformatics single cell bioinformatics evolutionary bioinformatics. Frontiers in Bioinformatics welcomes research that centers around new bioinformatics tools and novel applications that can bring insights to specific biological problems - efforts that cross standard field boundaries and bring approaches never before applied to biological data. This comprises the full spectrum of computational tools specific to analyzing biological data. The journal encourages the submission of manuscripts that advance the Sustainable Development Goals (SDGs) set by the United Nations, with a particular focus on SDG 14: life below water, SDG 15: life on land, SDG 4: quality education, SDG 9: industry, innovation, and infrastructure, and SDG 17: partnerships for the goals. Frontiers in Bioinformatics is a community partner of the International Meeting on Visualizing Biological Data (VIZBI), supporting the research community advancing methods and tools for biological data visualization and visual analytics. Manuscripts that focus solely on clinical oncology, cancer treatment, and patient care, without a clear relevance to bioinformatics, are not suitable for publication in this journal. Studies that do not utilize computational methods to analyze biological data or do not contribute to the development of bioinformatics tools and resources fall outside the journal's scope. Please note this journal does not accept mendelian randomization or bibliometric studies. Frontiers in Bioinformatics commitment is to advance research on data-driven approaches to analyze biological data, recognizing the increasing importance of combined methods in the field, by allowing unrestricted access to articles and communicating scientific knowledge to researchers and the public to enable future scientific breakthroug
From the journal's Aims & Scope
Research area (LetPub): Mathematics-Statistics and Probability
Editorial board by country: 2 in mainland China (about 11%); most named United States 5, Australia 3, Mainland China 2, United Kingdom 2, India 2 (18 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Bioinformatics and Genomic NetworksBiochemistry, Genetics and Molecular Biology10.2%
- Genomics and Phylogenetic StudiesBiochemistry, Genetics and Molecular Biology10.1%
- Computational Drug Discovery MethodsComputer Science7.7%
- Machine Learning in BioinformaticsBiochemistry, Genetics and Molecular Biology7.3%
- Cell Image Analysis TechniquesBiochemistry, Genetics and Molecular Biology7.1%
- Single-cell and spatial transcriptomicsBiochemistry, Genetics and Molecular Biology6.1%
- Gene expression and cancer classificationBiochemistry, Genetics and Molecular Biology5.7%
- vaccines and immunoinformatics approachesBiochemistry, Genetics and Molecular Biology4.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 4 |
| Minor | Mathematical & Computational Biology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Mathematical & Computational Biology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePMCPublisher website
Other: EBSCO, ProQuest, Dimensions, CNKI, CLOCKSS, Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 3.6Publisher website ·
- CiteScore 2026-06
- 6.6LetPub ·
- CiteScore (publisher)
- 6.6Publisher website ·
- SJR 2026-06
- 1.34LetPub ·
- SNIP 2026-06
- 1.3LetPub ·
- h-index
- 33OpenAlex ·
- i10-index
- 160OpenAlex ·
- 2-year mean citedness
- 2.37OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 157LetPub ·
Articles by year OpenAlex count · 834 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 277 | 277 | 110 |
| 2025 | 165 | 165 | 395 |
| 2024 | 83 | 83 | 739 |
| 2023 | 112 | 112 | 1,423 |
| 2022 | 126 | 126 | 3,306 |
| 2021 | 71 | 71 | 986 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
63 daysMedian, submission to acceptance · P25–P75 43 days – 90 days
- Acceptance to online
- median 27 days (115 articles)
- Submission to online
- median 97 days
- Sample
- 115 articles with submission and acceptance dates (437 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 13 weeksLetPub ·
- Submission to publication (journal-reported)
- about 13 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | CHF 2,550 | Yes | CC BY | |
| OpenAlex | CHF 2,550 | — | — | |
| LetPub | USD 2,125 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Keywords
- 5–8
- Reference style
- Harvard
- Templates
- LaTeX and Word
Policy excerpts from the journal's websiteAI use, Conflicts of interest, License & copyright, Open access, Peer review
- AI use Use of AI to create written or visual content
Authors should not list a generative AI technology as a co-author or author of any submitted manuscript. Generative AI technologies cannot be held accountable for all aspects of a manuscript and consequently do not meet the criteria required for authorship. If the author of a submitted manuscript has used written or visual content produced by or edited using a generative AI technology, this use mu…
Source ↗Publisher website ·- Conflicts of interest Safeguards against financial conflicts of interest
Only leading researchers acting as Associate Editors, who are not part of Frontiers' staff, can make acceptance decisions based on reviews performed by external experts acting as Community Reviewers or Reviewers. None have a financial incentive to accept articles, i.e. they are not paid for their role as Associate Editor or community Reviewer, and any award scheme is not linked to acceptances of m…
Source ↗Publisher website ·- License & copyright Open access and copyright
All Frontiers' articles from July 2012 onwards are published with open access under the Creative Commons CC-BY license (the current version is CC-BY, version 4.0). This means that the author(s) retains copyright, but the content is free to download, distribute, and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article. Upon submission, the author(s)…
Source ↗Publisher website ·- Open access Open access and copyright
APCs apply to accepted articles. Model summary
All Frontiers' articles from July 2012 onwards are published with open access under the Creative Commons CC-BY license (the current version is CC-BY, version 4.0). This means that the author(s) retains copyright, but the content is free to download, distribute, and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article. Upon submission, the author(s)…
Source ↗Publisher website ·- Peer review Peer review
Peer review process described as rigorous and transparent, combining expert review and constructive dialogue. Model summary
Our rigorous, transparent peer review process combines expert review and constructive dialogue to strengthen your manuscript.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Frontiers Media S.A.
- Country or region
- Switzerland
- Language
- English
- ISSN
- 2673-7647
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Frontiers in Bioinformatics
What CAS zone is Frontiers in Bioinformatics in?
In the 2025 upgraded edition of the CAS Journal Ranking, Frontiers in Bioinformatics is in Zone 4 of Biology, and in Zone 4 of the minor category Mathematical & Computational Biology. In the 2026 Xinrui edition it is in Zone 3 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Frontiers in Bioinformatics?
The journal's website gives an impact factor of 3.6; this is the journal's own figure, as LetPub lists none for it; CiteScore 6.6, h-index 33.
How long does peer review take at Frontiers in Bioinformatics?
Based on the dates recorded on 115 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 63 days (interquartile range 43–90 days); authors report an average review time of about 13 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Frontiers in Bioinformatics?
According to the journal's author guidelines: Keywords: 5–8; Reference style: Harvard; Templates: LaTeX and Word. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Frontiers in Bioinformatics based?
Of the 18 board members whose country the journal's board page names, 2 (about 11%) are in mainland China; the countries named most often are United States (5), Australia (3) and Mainland China (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Frontiers in Bioinformatics?
According to LetPub and DOAJ records, Frontiers in Bioinformatics is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Web of Science and PMC; that list has not been checked against each database.
Is Frontiers in Bioinformatics open access, and what is the APC?
Frontiers in Bioinformatics is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .